All companies › NBIX

NBIX · NEUROCRINE BIOSCIENCES INC

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells3
Research cases0
Last filing2026-09-14

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-09 — BENEVICH ERIC · sold 2,154 @ $154.61 2026-09-14 — ABERNETHY MATT · sold 2,311 @ $157.20 2026-09-14 — Boyer David W. · sold 826 @ $157.45
2026-09-092026-09-14

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

BENEVICH ERIC Chief Commercial Officer
ABERNETHY MATT Chief Financial Officer
Boyer David W. Chief Corp. Affairs Officer
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $NBIX is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-14', 'insider_name': 'ABERNETHY MATT', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 2311.0, 'price': 157.2, 'value': 363289.2, 'is_buy': False}, {'transaction_date': '2026-09-14', 'insider_name': 'Boyer David W.', 'insider_title': 'Chief Corp. Affairs Officer', 'transaction_type': 'Open-market sell', 'shares': 826.0, 'price': 157.45, 'value': 130053.7, 'is_buy': False}, {'transaction_date': '2026-09-09', 'insider_name': 'BENEVICH ERIC', 'insider_title': 'Chief Commercial Officer', 'transaction_type': 'Open-market sell', 'shares': 2154.0, 'price': 154.61, 'value': 333029.94, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for NBIX today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.